cholesteryl octanoate
cholesteryl caprylate
Identification
| Name | cholesteryl octanoate |
| IUPAC | [(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] octanoate |
| CAS Number | 1182-42-9 |
| EINECS | 214-656-2 |
| FDA UNII | X9U26HA4Z2 |
| Molecular Formula | C35 H60 O2 |
| Molecular Weight | 512.86160000 |
| MDL Number | MFCD00003642 |
| Nikkaji Number | J203.438G |
Regulatory
Physical Properties
| Assay | 95.00 to 100.00 |
| Food Chemicals Codex Listed | No |
| Boiling Point | 565.00 °C. @ 760.00 mm Hg (est) |
| Flash Point | 561.00 °F. TCC ( 293.70 °C. ) (est) |
| logP (o/w) | 13.599 (est) |
| Soluble in | water, 8.601e-009 mg/L @ 25 °C (est) |
No sensory data available
Safety Information
| Preferred SDS | View |
| Oral/Parenteral Toxicity | Not determined |
| Dermal Toxicity | Not determined |
| Inhalation Toxicity | Not determined |
GHS Classification
['GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)', 'GHS Label elements, including precautionary statements']
Safety in Use
| Category | information only not used for fragrances or flavors |
| Recommendation for cholesteryl octanoate usage levels up to | not for fragrance use. |
| Recommendation for cholesteryl octanoate flavor usage levels up to | not for flavor use. |
Potential Uses
Natural Occurrence
Synonyms
(3b)-
cholest-5-en-3-yl octanoate
cholest-5-ene-3-beta-yl octanoate
cholesterol N-octanoate
cholesteryl caprylate
cholesteryl N-octanoate
[(3S,8S,9S,10R,13R,14S,17R)-10,13-
dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] octanoate
3b-
hydroxy-5-cholestene 3-octanoate
octanoic acid, (3b)-cholest-5-en-3-yl ester
PubMed:
(13)C breath tests for the assessment of exocrine pancreatic function.
PubMed:
Cholesteryl butyrate solid lipid nanoparticles inhibit adhesion of human neutrophils to endothelial cells.
PubMed:
Measurement of gastric emptying by the 13C-octanoate breath test--rationalization with scintigraphy.
PubMed:
Modified 13C-octanoate breath test and impact of sampling points.
PubMed:
"Mixed" triglyceride breath test: methodological problems and clinical applications.
PubMed:
Gastric transit and pharmacodynamics of a two-millimeter enteric-coated pancreatin microsphere preparation in patients with chronic pancreatitis.
PubMed:
13C labelled cholesteryl octanoate breath test for assessing pancreatic exocrine insufficiency.
PubMed:
Bile salt-stimulated lipase and digestion of non-breast milk fat.
PubMed:
Comparative effects of enteric-coated pancreatin microsphere therapy after conventional and pylorus-preserving pancreatoduodenectomy.
PubMed:
Simultaneous assessments of exocrine pancreatic function by cholesteryl-[14C]octanoate breath test and measurement of plasma p-aminobenzoic acid.
PubMed:
New methods for assessment of enzyme activity: do they help to optimize enzyme treatment?
PubMed:
Crystal structure of cholestanyl caprylate and binary phase behavior with cholesteryl caprylate.
PubMed:
Monitoring enzyme replacement treatment in exocrine pancreatic insufficiency using the cholesteryl octanoate breath test.
PubMed:
Eutectic interactions between saturated and unsaturated chain cholesteryl esters: comparison of calculated and observed phase diagrams.
PubMed:
Cholesteryl octanoate breath test. Preliminary studies on a new noninvasive test of human pancreatic exocrine function.
PubMed:
The cholesteryl octanoate breath test: a new procedure for detection of pancreatic insufficiency in the rat.
PubMed:
Novel surface phase containing cholesteryl esters. 2. Nonequivalence of cholesteryl arachidonate and those with 18-carbon, cis-unsaturated acyl groups.